IN BRIEF: Renalytix gets USD4 million balance sheet boost
10th Oct 2025 18:14
Renalytix PLC - London-based diagnostics company - Reports Heights Capital Ireland LLC-advised fund notifies company that approximately USD4 million of non-amortising senior convertible bonds will be capitalised. Says 31.7 million ordinary shares will be issued at 9.5 pence each, the same price as Renalytix's recent fundraise, which raised just over GBP1.0 million. Renalytix says the bond conversion will improve its debt-to-equity ratio and significantly improve its balance sheet, improving its net asset position by around USD4 million and saving up to USD1.4 million in accrued interest over the remaining life of the loan. Read More